AI assistant
BIO-RAD LABORATORIES, INC. — Director's Dealing 2015
Sep 11, 2015
30786_dirs_2015-09-10_73d36809-723f-42e4-b83b-94c0caa7126f.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: BIO RAD LABORATORIES INC (BIO, BIOB)
CIK: 0000012208
Period of Report: 2015-09-08
Reporting Person: Hall Shannon (Executive Vice President)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2015-09-08 | Bio-Rad A Common Stock | M | 220 | — | Acquired | 1313.2707 | Direct |
| 2015-09-09 | Bio-Rad A Common Stock | S | 84 | $139.01 | Disposed | 1229.2707 | Direct |
Derivative Transactions
| Date | Security | Exercise Price | Code | Shares | A/D | Expiration | Underlying | Ownership |
|---|---|---|---|---|---|---|---|---|
| 2015-09-08 | Restricted Stock Units | $0 | M | 220 | Disposed | Bio-Rad A Common Stock (220) | Direct |
Footnotes
F1: Shares of Class A common stock acquired on the vesting of restricted stock units.
F2: Includes 2.6248, 82.5310 and 89.0382 shares acquired under the Bio-Rad Employee Stock Purchase Plan on 12/31/14, 3/31/15 and 6/30/15, respectively.
F3: Sold by the issuer on behalf of the reporting person to satisfy certain tax obligations in connection with the vesting of restricted stock units, all in accordance with a restricted stock unit award agreement.
F4: Each restricted stock unit represents a contingent right to receive one share of Bio-Rad Class A common stock.
F5: The restricted stock units vest in five equal annual installments beginning September 8, 2011.